Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/pbc.29240 http://scihub22266oqcxt.onion/10.1002/pbc.29240 34264546!8441810!34264546     free     free     free       Pediatr+Blood+Cancer 2021 ; 68 (10): e29240 Nephropedia Template TP {{tp|p=34264546|t=2021. SARS-CoV-2 vaccination for adolescents and young adult patients treated at a specialist pediatric oncology unit |pdf=|usr=}}{{34264546}} gab.com Text SARS-CoV-2 vaccination for adolescents and young adult patients treated at a specialist pediatric oncology unit JO: Pediatr Blood Cancer http://www.kidney.de/pget.php?&tw=1&pmid=34264546 #FOAvip This brief report describes the SARS-CoV-2 vaccination program at our pediatric oncology unit. Adopting Italian regulations, patients treated for cancer within the previous 6 months were offered vaccination with the Pfizer-BioNtech vaccine if aged >/=16 years, and with the Pfizer-BioNtech or Moderna vaccine if aged >/=18 years. From March 24 to April 28, 2021, 80/89 adolescent and young adult patients enrolled were vaccinated, while nine refused the vaccine due to fear of side effects, disbelief regarding the pandemic, or lack of trust in the scientific community. The refusal rate in our cohort was lower than in the Italian general population. Twit Text FOAVip SARS-CoV-2 vaccination for adolescents and young adult patients treated at a specialist pediatric oncology unit ????Pediatr Blood Cancer http://www.kidney.de/pget.php?&tw=1&pmid=34264546 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34264546 #FOAvip English Wikipedia <ref>{{Cite pmid|34264546}}</ref> SARS-CoV-2 vaccination for adolescents and young adult patients treated at a specialist pediatric oncology unit #MMPMID34264546 Nigro O; Sironi G; Bergamaschi L; Gattuso G; Puma N; Livellara V; Chiaravalli S; Ferrari A; Massimino M Pediatr Blood Cancer 2021[Oct]; 68 (10): e29240 PMID34264546show ga This brief report describes the SARS-CoV-2 vaccination program at our pediatric oncology unit. Adopting Italian regulations, patients treated for cancer within the previous 6 months were offered vaccination with the Pfizer-BioNtech vaccine if aged >/=16 years, and with the Pfizer-BioNtech or Moderna vaccine if aged >/=18 years. From March 24 to April 28, 2021, 80/89 adolescent and young adult patients enrolled were vaccinated, while nine refused the vaccine due to fear of side effects, disbelief regarding the pandemic, or lack of trust in the scientific community. The refusal rate in our cohort was lower than in the Italian general population. |*Medical Oncology[MESH] |Adolescent[MESH] |Adult[MESH] |COVID-19 Vaccines/*administration & dosage[MESH] |COVID-19/diagnosis/*prevention & control/virology[MESH] |Female[MESH] |Hospitals, Pediatric/*statistics & numerical data[MESH] |Humans[MESH] |Male[MESH] |SARS-CoV-2/*isolation & purification[MESH] |Treatment Outcome[MESH] |Vaccination/*statistics & numerical data[MESH]SARS-CoV-2 vaccination for adolescents and young adult patients treate(epmc).pdf DeepDyve Pubget Overpricing